In Conversation

We need partners who understand that our mission is more than a business

We now have the scientific tools to end the HIV epidemic; the challenge lies in delivery

After so many years of globalization, it is clear that we are interdependent and interconnected. Cutting off the channels of cooperation would lead to harm on…

We are in the business of excellent clinical evidence. EMA wants to partner with stakeholders, including those from industry, to drive up the quality of evidence…

Our dedication to advancing technology and making tangible differences in healthcare is unwavering. Partnering with Jacobio Pharmaceuticals offers a unique opportunity to collaborate on groundbreaking initiatives…

Our commitment to finding effective treatments for patients across the region remains unwavering

The reluctance to invest in phase one trials is multifaceted. One aspect is the fear of generic molecule development in India, even though the regulatory environment…

We are steadfast in our mission to ensure the availability of pharmaceutical products and supplies, particularly in the face of widespread shortages and surpluses

An alarming statistic is that half of the individuals with diabetes remain undiagnosed. Moreover, Indians tend to develop diabetes a decade earlier than their Western counterparts,…

India contributes nearly 90 percent of the global production of castor oil, and we export our product to almost every corner of the world

One of the prominent challenges the country is facing is the over-dependency on China for APIs. As a country we want to avoid this dependency and…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here